Recruiting × OTHER × Carcinoma, Transitional Cell × Clear all PNeoVCA
Phase 1/2 Recruiting
132 enrolled
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Recruiting
300 enrolled
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
Phase NA Recruiting
20 enrolled
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Phase NA Recruiting
128 enrolled
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Recruiting
300 enrolled
P-EVOLUTION
Recruiting
80 enrolled
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Phase 2 Recruiting
23 enrolled
IMPROEV
Phase 2 Recruiting
97 enrolled
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
Phase 2 Recruiting
24 enrolled
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
Recruiting
180 enrolled
SOGUG-PRINCIS
Recruiting
500 enrolled
Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
Phase NA Recruiting
70 enrolled
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
Recruiting
50 enrolled
Circulating Tumor DNA Response In Urothelial Cancer
Phase 2 Recruiting
30 enrolled
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Phase NA Recruiting
600 enrolled
FLORAL
Recruiting
50 enrolled
OUAF
Recruiting
340 enrolled
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Phase 1 Recruiting
20 enrolled
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Recruiting
178 enrolled
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2 Recruiting
27 enrolled
TRAIN-UC-01
Phase 2 Recruiting
96 enrolled
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Phase 2 Recruiting
50 enrolled
Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
Phase NA Recruiting
200 enrolled
Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/2 Recruiting
106 enrolled
INSITE
Recruiting
92 enrolled
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Phase 2 Recruiting
70 enrolled
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Phase NA Recruiting
40 enrolled
UROSCOUT-1
Recruiting
3,000 enrolled
TALASUR
Phase 2 Recruiting
50 enrolled
ST-ICI02
Recruiting
200 enrolled
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
Phase 2 Recruiting
147 enrolled
Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients
Phase NA Recruiting
58 enrolled
Ivonescimab in the Treatment of Multiple Advanced Tumors
Phase 2 Recruiting
400 enrolled
GRAPE
Phase 2 Recruiting
43 enrolled
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Phase 1 Recruiting
30 enrolled
DP-PAN-CANCER
Phase NA Recruiting
450 enrolled
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
Phase 2 Recruiting
55 enrolled
MOIO
Phase 3 Recruiting
646 enrolled
Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
Phase 2 Recruiting
44 enrolled
Urolife
Recruiting
50 enrolled
Bladder Cancer Screening Trial
Phase NA Recruiting
1,000 enrolled
Adjuvant Sacituzumab Govitecan and Nivolumab in Muscle-Invasive Urothelial Carcinoma At High-Risk Recurrence
Phase 2 Recruiting
23 enrolled
ADAPT-BLADDER
Phase 1/2 Recruiting
55 enrolled
MicroBlad
Recruiting
1,000 enrolled
Urine Omics Predicting IO Therapy Responses in mUC Patients
Recruiting
600 enrolled
POSITive
Recruiting
265 enrolled
A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 Recruiting
36 enrolled
CIRCE
Recruiting
450 enrolled
CHASIT
Phase 2 Recruiting
64 enrolled
SeARCH
Phase NA Recruiting
1,100 enrolled